Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRecruitment status on the study page is updated to 'No longer looking for participants', indicating the study is not enrolling new participants. The page also adds new help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and changes the label from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check10 days agoChange DetectedThe page now includes a Revision: v3.5.5 tag, replacing the previous Revision: v3.5.4. This indicates the page record has been updated to version 3.5.5.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page's content or styling. This change appears to be a maintenance/update rather than an alteration to the study details or content.SummaryDifference0.0%

- Check52 days agoChange DetectedUpdated the page’s revision/version indicator from v3.5.2 to v3.5.3, reflecting a minor platform or display update rather than a substantive change to the study record.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check89 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.